Neurology: Cognitive-Behavioral Screening Reveals Prevalent Impairment in a Large Multicenrer Amyotrophic Lateral Sclerosis (ALS) Cohort is organized by American Academy of Neurology (AAN) and will be held during Mar 01, 2016 - Mar 01, 2019.
The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Learning Objectives :
Upon completion of the article by Murphy et al, the participant should be able to:
State the rate at which mild to moderate cognitive impairment is observed in patients with amyotrophic lateral sclerosis (ALS) in this cohort
Describe the association between C9orf72 hexanucleotide repeat status and cognitive-behavioral dysfunction in patients with ALS in this cohort
Identify common behavioral disturbances that are associated with cognitive impairment in patients with ALS.
Additional details will be posted as soon as they are available.